Profile
Colin Sims is currently the Chief Executive Officer & Director at Adthera Bio Ltd.
and the Senior Partner at Delin Ventures Ltd.
Previously, he worked as the Managing Director at Accenture (UK) Ltd.
from 2013 to 2017 and as the Senior Vice President at Sanofi from 2018 to 2019.
Dr. Sims holds a graduate degree from the University of London and a doctorate degree from King's College London.
Colin Sims active positions
| Companies | Position | Start |
|---|---|---|
Delin Ventures Ltd.
 Delin Ventures Ltd. Investment ManagersFinance Delin Ventures Ltd. (Delin Ventures) is a venture capital firm founded in 2013 by Igor Linshits. The firm headquartered in London, United Kingdom. | Private Equity Investor | 2022-07-31 |
Former positions of Colin Sims
| Companies | Position | End |
|---|---|---|
| SANOFI | Private Equity Investor | 2019-06-30 |
Accenture (UK) Ltd.
 Accenture (UK) Ltd. Miscellaneous Commercial ServicesCommercial Services Accenture (UK) Ltd. provides strategy, consulting, outsourcing, and technology services. The company was founded on May 8, 2003 and is headquartered in London, the United Kingdom. | Private Equity Investor | 2017-02-28 |
Training of Colin Sims
| King's College London | Doctorate Degree |
| University of London | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| SANOFI | Health Technology |
| Private companies | 2 |
|---|---|
Delin Ventures Ltd.
Delin Ventures Ltd. Investment ManagersFinance Delin Ventures Ltd. (Delin Ventures) is a venture capital firm founded in 2013 by Igor Linshits. The firm headquartered in London, United Kingdom. | Finance |
Accenture (UK) Ltd.
Accenture (UK) Ltd. Miscellaneous Commercial ServicesCommercial Services Accenture (UK) Ltd. provides strategy, consulting, outsourcing, and technology services. The company was founded on May 8, 2003 and is headquartered in London, the United Kingdom. | Commercial Services |
- Stock Market
- Insiders
- Colin Sims
